References
- Hozumi I, Asanuma M, Yamada M, Uchida Y. Metallothioneins and neurodegenerative diseases. J Health Science. 2004; 50: 323–31
- Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. The growth inhibitory factor that is deficient in Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 1991; 7: 337–47
- Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowics BP, et al. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epththelia. Biochemistry. 1994; 33: 7250–9
- Uchida Y, Gomi F, Masumizu T, Miura Y. Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J Biol Chem. 2002; 277: 32353–9
- Nagano S, Satoh M, Sumi H, Fujimura H, Tohyama C, Yanagihara T, et al. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur J Neurosci. 2001; 13: 1363–70
- Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci. 2002; 22: 8790–6
- Tokuda E, Ono S, Ishige K, Naganuma A, Ito Y, Suzuki T. Metallothionein proreins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis. Toxicol. 2007; 229: 33–41
- Ishigaki S, Niwa J, Ando Y, Yoshihara T, Sawada K, Doyu M, et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords screened by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett. 2002; 531: 354–8
- Blaauwgeers HGT, Chand M A, van den Berg FM, Vianney JMB, Troost D. Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis. J Neurol Sci. 1996; 142: 39–44
- Cirelli C, Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res. 2000; 885: 303–21
- Yeiser EC, Fitch CA, Horning MS, Rutkoski N, Levenson CW. Regulation of metallothionein-3 mRNA by thyroid hormone in developing rat brain and primary cultures of rat astrocytes and neurons. Dev Brain Res. 1999; 115: 195–200
- Yamada M, Hayashi S, Hozumi I, Inuzuka T, Tsuji S, Takahashi H. Subcellular localization of growth inhibitory factor in rat brain: light and electron microscopic immunohistochemical studies. Brain Res. 1996; 735: 257–64
- Hozumi I, Inuzuka T, Ishiguro H, Hiraiwa M, Uchida Y, Tsuji S. Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds: an immunocytochemical study using confocal laser scan microscope. Brain Res. 1996; 741: 197–204
- Sakamoto T, Kawazoe Y, Uchida Y, Hozumi I, Inuzuka T, Watabe K. Growth inhibitory factor prevents degeneration of injured adult rat motoneurons. NeuroReport. 2003; 14: 2147–51
- Hozumi I, Uchida Y, Watabe K, Sakamoto T, Inuzuka T. Growth inhibitory factor (GIF) can protect from brain damage due to stab wounds in rat brain. Neurosci Lett. 2006; 395: 220–3
- Penkowa M, Hidalgo J. Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair experimental autoimmune encephalomyelitis. J Neurosci Res. 2003; 72: 574–86